Synonyms:1,4-benzodiazepine;1,4-benzodiazepine-2,5-dione;2H-1,4-benzodiazepin-2-one, 7-chloro-1,3-dihydro-5-(4-hydroxyphenyl)-1-methyl-3-(2-naphthalenylmethyl)-;BZ 423;Bz-423
99% *data from raw suppliers
The research focuses on the synthesis of 1,2-annelated 1,4-benzodiazepines and 4,1-benzoxazepines, which are part of a study on compounds with heterocyclic seven-membered rings. The key step in the synthesis process involves a nucleophilic aromatic substitution with activated aryl halides and 2-substituted piperazines, piperidines, or pyrrolidines. The study successfully synthesized the target compounds using various substituted aryl halides and heterocyclic compounds, demonstrating the versatility of the method. The chemicals used in the process include 2-fluor-5-nitrobenzonitrile, 4-methylpiperazin-2-carbonsaure-athylester, and other substituted benzene derivatives, among others, to achieve the desired heterocyclic compounds. The conclusions of the research provide a detailed methodology for synthesizing these complex heterocycles, which are important in the field of medicinal chemistry due to their potential pharmacological properties.
The research focuses on the development of 1,4-benzodiazepine derivatives as Cholecystokinin (CCK-A) receptor agonists for the treatment of obesity. The purpose of the study was to synthesize and screen a series of 1,4-benzodiazepines, specifically N-1-substituted with an N-isopropyl-N-phenylacetamide moiety, for their ability to activate CCK-A receptors, which regulate satiety and could potentially be used as a pharmacotherapeutic intervention for obesity. The researchers demonstrated in vitro agonist activity on isolated guinea pig gallbladder and in vivo induction of satiety in a rat feeding assay following intraperitoneal administration. The study concluded that a novel series of potent and efficacious 1,4-benzodiazepine and 1,4-benzodiazepine-4-N-oxide CCK-A agonists were successfully developed, which showed promising results in both in vitro and in vivo assays. Key chemicals used in the process included 3-amino-1,4-benzodiazepine core, N-isopropyl-N-phenylacetamide (agonist trigger), bromoacetamides, and various substituents at the C-3 position such as phenyl ureas, anilino acetamides, and indolylmethyl groups.
This research presents a novel four-step synthesis of the pyrrolo[2,1-c][1,4]benzodiazocine ring system. The purpose of this study is to develop an efficient and straightforward route to synthesize this ring system, which is structurally related to the pharmacologically important 1,4-benzodiazepine central nervous system agents. The synthesis involves alkylation of 1H-pyrrole-2-carbaldehyde with ethyl or methyl bromoacetate, oxidation of the resulting esters with potassium permanganate, conversion of the acids to acid chlorides using thionyl chloride, and finally a Dieckmann condensation to form the pyrrolo[2,1-c][1,4]benzodiazocine ring. The study concludes that this new synthetic route is efficient and provides a practical method for the synthesis of the pyrrolo[2,1-c][1,4]benzodiazocine ring system, potentially facilitating further research and development of related pharmaceutical compounds.
The research aimed to synthesize a series of N'-substituted 1,4-benzodiazepine-1-carbothioamides (2a-j) and investigate their anti-HIV activity. The researchers used a precursor, 1,4-benzodiazepine 11, and reacted it with various N-substituted isothiocyanates or sodium thiocyanate-trifluoroacetic acid to create the target compounds. Key chemicals involved in the synthesis included 2-aminobenzyl alcohol, di-tert-butyl dicarbonate, carbon tetrabromide, triphenylphosphine, L-alanine, and different isothiocyanates. Despite the structural resemblance of these molecules to the potent TIBO-type anti-HIV compound R82150, none of the synthesized compounds displayed anti-HIV activity in vitro, suggesting that the potent anti-HIV activity of TIBO derivatives requires an intact tricyclic structure.
What can I do for you?
Get Best Price
Total 8 Pictures about this product
